{"id":802619,"date":"2026-04-16T13:38:02","date_gmt":"2026-04-16T13:38:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=802619"},"modified":"2026-04-16T13:38:02","modified_gmt":"2026-04-16T13:38:02","slug":"global-tissue-diagnostics-market-set-to-reach-1086-billion-by-2030-amid-rising-cancer-burden-and-diagnostic-innovation","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/global-tissue-diagnostics-market-set-to-reach-1086-billion-by-2030-amid-rising-cancer-burden-and-diagnostic-innovation_802619.html","title":{"rendered":"Global Tissue Diagnostics Market Set to Reach $10.86 Billion by 2030 Amid Rising Cancer Burden and Diagnostic Innovation"},"content":{"rendered":"<div style=\"float:right;  width:250px; padding:8px 10px 10px 10px;\"><a href=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1776332719.jpg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Global Tissue Diagnostics Market Set to Reach $10.86 Billion by 2030 Amid Rising Cancer Burden and Diagnostic Innovation\" src=\"https:\/\/www.abnewswire.com\/upload\/2026\/04\/1776332719.jpg\" alt=\"Global Tissue Diagnostics Market Set to Reach $10.86 Billion by 2030 Amid Rising Cancer Burden and Diagnostic Innovation\" width=\"225\" height=\"225\" \/><\/a><\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Tissue Diagnostics Market by Product (Consumables [Antibodies, Kits, Reagents, Probes], Instruments [Systems, Scanner], Software, Services), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) &#8211; Global Forecast to 2030<\/div>\n<p style=\"text-align: justify;\"><strong>According to MarketsandMarkets&trade;,<\/strong> the <strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/tissue-diagnostics-market-1063949.html?utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">tissue diagnostics market<\/a><\/strong> is projected to grow from USD 6.74 billion in 2025 to USD 10.86 billion by 2030, registering a robust CAGR of 10.0% during the forecast period.The global tissue diagnostics market is entering a phase of accelerated growth, driven by the urgent need for precision oncology and scalable diagnostic infrastructure.<\/p>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure: <a rel=\"nofollow\" name=\"www_marketsandmarkets_com_pdfdownlo\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=1063949&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=1063949<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Browse<\/strong><\/p>\n<ul style=\"text-align: justify;\">\n<li><strong>568 <\/strong>Market Data Tables<\/li>\n<li><strong>54 <\/strong>Figures<\/li>\n<li><strong>420 <\/strong>Pages and in-depth TOC on<strong> &#8220;<\/strong> <strong>Tissue Diagnostics Market <strong>&#8211; Global Forecast to 2030&rdquo;.<\/strong><\/strong><\/li>\n<\/ul>\n<p style=\"text-align: justify;\">&nbsp;<\/p>\n<p style=\"text-align: justify;\"><strong>What is fueling this momentum, and why does it matter now? <\/strong><\/p>\n<p style=\"text-align: justify;\">The market&rsquo;s expansion is primarily underpinned by the rising global incidence of cancer and the increasing demand for accurate, timely, and reliable diagnostic solutions. As healthcare systems worldwide confront growing oncology caseloads, how can providers ensure early detection and effective treatment planning? Tissue diagnostics technologies&mdash;spanning immunohistochemistry (IHC), in situ hybridization (ISH), and slide staining&mdash;are becoming indispensable tools in enabling precise disease characterization and personalized therapies.<\/p>\n<p style=\"text-align: justify;\">Simultaneously, the rapid proliferation of private diagnostic centers is reshaping the diagnostic landscape. Where is this growth most impactful? Emerging and developed markets alike are witnessing increased access to specialized pathology services, allowing laboratories to adopt advanced diagnostic systems and high-quality reagents. This shift not only improves clinical outcomes but also standardizes workflows, enhancing efficiency across both clinical and research environments.<\/p>\n<p style=\"text-align: justify;\">From a product and service perspective, consumables&mdash;including antibodies, reagents, kits, and probes&mdash;accounted for the largest market share in 2024. Why do consumables dominate? Their recurring usage in every diagnostic assay ensures consistent demand, while the growing adoption of automated and high-throughput systems further amplifies their importance. As laboratories scale operations, the need for reliable, standardized consumables becomes critical to maintaining diagnostic accuracy and operational efficiency.<\/p>\n<p style=\"text-align: justify;\">By end user, hospitals emerged as the leading segment, reflecting their central role in patient care and diagnostics. Who are the primary adopters of tissue diagnostics technologies? Hospitals, with their high patient volumes and increasing investment in advanced pathology labs, rely heavily on these solutions for diagnosis, treatment planning, and disease monitoring. This positions them as key drivers of market demand and innovation adoption.<\/p>\n<p style=\"text-align: justify;\"><strong>Regional Analysis: <\/strong><\/p>\n<p style=\"text-align: justify;\">Regionally, North America continues to lead the global tissue diagnostics market. What factors sustain its dominance? The region benefits from advanced healthcare infrastructure, significant healthcare expenditure, and widespread adoption of cutting-edge diagnostic technologies such as digital pathology and automated tissue processing systems. Additionally, strong R&amp;D capabilities and supportive regulatory frameworks further reinforce market growth across the US and Canada.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages: <a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=1063949&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=1063949<\/a><\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Key Leading industry players:<\/strong><\/p>\n<p style=\"text-align: justify;\">Leading industry players&mdash;including F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), PHC Holdings Corporation (Japan), Merck KGaA (Germany), and Agilent Technologies (US)&mdash;are actively investing in innovation, product development, and strategic collaborations. How are these companies shaping the market? By advancing diagnostic accuracy, integrating digital solutions, and expanding global reach, they are setting new benchmarks in tissue diagnostics and precision medicine.<\/p>\n<p style=\"text-align: justify;\"><strong>Why This Matters Now:<\/strong><\/p>\n<p style=\"text-align: justify;\">As healthcare systems worldwide prioritize early diagnosis and personalized treatment, tissue diagnostics is becoming a strategic cornerstone in oncology care. For C-suite leaders and decision-makers, the market&rsquo;s trajectory signals significant opportunities for investment, partnerships, and technology adoption to enhance diagnostic capabilities and improve patient outcomes.<\/p>\n<p style=\"text-align: justify;\"><strong>Related Reports:<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=703&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">In Vitro Diagnostics Market<\/a> &#8211; Global Forecast to 2030<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong><a rel=\"nofollow\" href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=436&amp;utm_source=abnewswire.com&amp;utm_medium=referral&amp;utm_campaign=paidpr\">Immunoassay Market<\/a> &#8211; Global Forecast to 2030<\/strong><\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_145966.html\" rel=\"nofollow\">MarketsandMarkets\u2122 Research Private Ltd.<\/a><br \/><strong>Contact Person:<\/strong> Mr. Rohan Salgarkar<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=global-tissue-diagnostics-market-set-to-reach-1086-billion-by-2030-amid-rising-cancer-burden-and-diagnostic-innovation\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>1615 South Congress Ave.  Suite 103, Delray Beach, FL 33445<br \/><strong>City:<\/strong> Florida<br \/><strong>State:<\/strong> Florida<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/tissue-diagnostics-market-1063949.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/tissue-diagnostics-market-1063949.html<\/a><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=global-tissue-diagnostics-market-set-to-reach-1086-billion-by-2030-amid-rising-cancer-burden-and-diagnostic-innovation\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Tissue Diagnostics Market by Product (Consumables [Antibodies, Kits, Reagents, Probes], Instruments [Systems, Scanner], Software, Services), Technology (ISH, IHC, Slide Staining), Disease Type (Breast Cancer, Lymphoma, Prostate Cancer) &#8211; Global Forecast to 2030 According to MarketsandMarkets&trade;, the tissue diagnostics market is &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/global-tissue-diagnostics-market-set-to-reach-1086-billion-by-2030-amid-rising-cancer-burden-and-diagnostic-innovation_802619.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,411,404],"tags":[],"class_list":["post-802619","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/802619","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=802619"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/802619\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=802619"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=802619"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=802619"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}